美国外科医生二尖瓣修复率差异显著:Medicare索赔数据分析
该回顾性分析利用2020至2022年全美Medicare索赔数据,纳入2072名外科医生实施的12339例二尖瓣手术,总体修复率为68.8%。多变量回归显示手术量、执业年限和地区与修复率显著相关,即使在高手术量医生中修复率变异仍很大。
要点
- 总体二尖瓣修复率为68.8%,但外科医生间差异显著。
- 每增加1例手术,修复率平均提高1.5%(95%CI 1.2%-1.8%)。
- 每增加1年执业,修复率平均提高1.4%(95%CI 0.8%-2%)。
核心结论
- Medicare受益者中二尖瓣修复率在外科医生间存在显著变异,即使在高手术量医生中也是如此。
研究设计与样本
- 回顾性分析100% Medicare按服务收费索赔数据,覆盖2020年1月至2022年12月,共2072名外科医生在770家医院实施的12339例二尖瓣手术。
主要发现
- 总体修复率为68.8%,每名外科医生3年期间二尖瓣手术中位数为3例(IQR 2-7),修复中位数为2例(IQR 1-5)。
- 312名(15%)外科医生每年实施超过10例二尖瓣手术,贡献了全国57%的修复量,该亚组中位修复率为77%,其中17%修复率低于50%,59%在50%-90%之间,24%高于90%。
- 每增加1例手术,修复率平均提高1.5%(95%CI 1.2%-1.8%,P<.001);每增加1年执业,平均提高1.4%(95%CI 0.8%-2%,P<.001)。
- 南部外科医生修复率中位数为71%(IQR 55%-85%),低于东北部的78%(IQR 68%-91%,P=.02)和中西部的86%(IQR 63%-92%,P=.04)。
临床怎么用
- 应关注外科医生手术量和执业年限对二尖瓣修复率的影响,并针对低修复率地区或医生开展质量改进。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Mitral valve repair is the preferred treatment for primary mitral regurgitation and offers significant short- and long-term advantages over valve replacement. This study was designed to evaluate the contemporary national mitral valve surgery practice patterns, focusing on the impact of surgeon-specific factors, such as operative volume and years of practice, on repair rates. METHODS: A retrospective analysis was conducted using 100% Medicare fee-for-service claims data over a 3-year period (January 2020 to December 2022). Mitral valve procedures were identified using specific Current Procedural Terminology codes. We excluded patients with active infective endocarditis, mitral stenosis, or a history of previous mitral valve repair or replacement. Multivariable binomial regression was used to assess the impact of surgeon-specific factors on repair rates. RESULTS: We identified 2072 surgeons in 770 hospitals who performed 12,339 mitral valve operations, with an overall repair rate of 68.8%. The median number of mitral valve operations performed per surgeon during the 3-year study period was 3 (interquartile range [IQR], 2-7), and the median number of mitral valve repairs was 2 (IQR, 1-5). A subset of 312 surgeons (15%) performed more than 10 mitral valve procedures each and more than one half (57%) of all repairs nationally. This subgroup's median repair rate was 77%, with significant variability within the group: 17% of surgeons had a repair rate below 50%, 59% had a repair rate between 50% and 90%, and 24% had a repair rate greater than 90%. Multivariable regression analysis indicated significant associations between repair rates and surgeon-specific factors, including surgical volume, years of practice, and region of practice. Each additional procedure was associated with a 1.5% average increase in repair rate likelihood (95% confidence interval, 1.2%-1.8%, P < .001), and each additional year of practice was associated with a 1.4% average increase (95% confidence interval, 0.8%-2%, P < .001). Regional differences were notable: surgeons in the South demonstrated lower repair rates (median 71%; IQR, 55%-85%) compared with those in the Northeast (median, 78%; IQR, 68%-91%, P = .02) and Midwest (median 86%; IQR, 63%-92%, P = .04). CONCLUSIONS: This study has identified significant variability in mitral valve repair rates among surgeons who treat Medicare beneficiaries. Notably, even among the surgeons responsible for most of these procedures, the variability in repair rates is pronounced. These findings suggest substantial opportunities to improve outcomes for patients undergoing mitral valve operations in North America.
引用
- Wang H, Dun C, Makary MA, et al. Wide variation in mitral valve repair rates among US surgeons: Analysis of Medicare claims data. J Thorac Cardiovasc Surg. 2024. PMID: 39461413. doi:10.1016/j.jtcvs.2024.10.035
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。